Researchers of Alzheimer’s, Other Neurological Diseases Say ‘Mini-Brains’ May Be Effective in Testing New Drugs

Researchers of Alzheimer’s, Other Neurological Diseases Say ‘Mini-Brains’ May Be Effective in Testing New Drugs
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed “mini-brains” that may present a more accurate and effective way of testing new drugs for many neurological disorders, such as Alzheimer’s disease. These human cell-derived structures, which represent an existing new alternative to animal testing, were recently discussed in a presentation at the American Association

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *